tenofovir disoproxil fumarate
AssetAlso called TDF, Tenofovir DF, Tenofovir DF (TDF), Tenofovir Disoproxil Fumarate (TDF)
Prodrug of tenofovir that inhibits hepatitis B viral polymerase, blocking viral DNA synthesis.
- Stage
- Approved
- Modality
- Small molecule
- Target
- OCA2
- 12
- Indications
- 212
- Trials
- 4
- Developers
Approved by the FDA on Oct 26, 2001 (NDA021356). 3 approvals stand. FDA
Indications
129 more
In the full profile
- Target and mechanism2
- Owner and partners4
- Trials212
- Evidence for its targets3
- Competitors12
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.